用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [专利权人] 包含 'WYETH LLC'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页172 条记录, 当前第1/18页。
公开号 公开日 申请号 申请日
1. AU2010270976B2 2014/3/20 AU20100270976 2010/6/21
专利标题:Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen 法律状态
专利权人WYETH LLC;
Sodium ibuprofen compositions and methods of manufacturing tablets and caplets comprising sodium ibuprofen are described. The formulation is advantageous because it allows for the formation of tablets having low sodium content and further provides tablets exhibiting improved physical stability high tablet hardness and high strength coupled with excellent dissolution and bioavailability characteristics. The formulations and processes are further advantageous because they can be produced in large ...


2. AU2014200704A1 2014/2/27 AU20140200704 2014/2/10
专利标题:Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen 法律状态
专利权人WYETH LLC;
Sodium Ibuprofen Tablets And Methods Of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen Abstract The invention broadly relates to sodium ibuprofen compositions and methods of manufacturing tablets and caplets comprising sodium ibuprofen are described. The formulation is advantageous because it allows for the formation of tablets having low sodium content and further provides tablets exhibiting improved physical stability, high tablet hardness and high strength, coupled with ...


3. US20140050721A1 2014/2/20 US13/874147 2013/4/30
专利标题:Antineoplastic combinations with mtor inhibitor, trastuzumab and/or hki-272 法律状态
专利权人WYETH LLC;
A combination of temsirolimus and trastuzumab in the treatment of cancer is provided. A combination of temsirolimus and HKI-272 is provided. A combination of a trastuzumab and a HKI-272 is also provided. Regimens and kits for treatment of metastatic breast cancer containing trastuzumab temsirolimus and/or HKI-272 optionally in combination with other anti-neoplastic agents or immune modulators are described.


4. NZ593502A 2013/12/20 NZ20100593502 2010/1/21
专利标题:A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement 法律状态
专利权人WYETH LLC;
Abstract 593502 The disclosure relates to a composition comprising vitamin B1 vitamin B2 niacin vitamin B6 pantothenic acid vitamin E vitamin C and selenium wherein the weight ratio of biotin to vitamin B1 is between 1:20 to 1:25; wherein the weight ratio of biotin to vitamin B2 is between 1 :20 to 1 :25; wherein the weight ratio of biotin to niacin is between 1:310 to 1:330; wherein the weight ratio of biotin to vitamin B6 is between 1:30 to 1:35; wherein the weight ratio of biotin to pantothen...


5. CA2725598C 2013/10/8
专利标题:Antineoplastic combinations containing hki-272 and vinorelbine 法律状态
专利权人WYETH LLC;
A combination of HKI-272 compound and a vinorelbine compound in the treatment of a neoplasm is provided. Regimens kits and methods for treatment of neoplasm including breast cancer including metastatic breast cancer and lung cancer using this combination optionally in combination with other anti-neoplastic agents or immune modulators are also described.


6. US20130261112A1 2013/10/3
专利标题:Cyclothiocarbamate derivatives as progesterone receptor modulators 法律状态
专利权人WYETH LLC;
Methods of using compounds which are progesterone receptor agonists for contraception and the treatment of progesterone-related maladies alone or in combination with an estrogen receptor agonist or progesterone receptor antagonist are provided. These compounds have the structure: wherein R1 R2 R3 R4 R5 and Q1 are defined herein.


7. CA2730715C 2013/10/1
专利标题:Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine 法律状态
专利权人WYETH LLC;
A combination of a 4-anilino-3-cyanoquinoline compound (e.g. HKI-272 SKI-606 EKB-569) and a capecitabine compound in the treatment of a neoplasm is provided. Regimens kits and methods for treatment of neoplasm including breast cancer including metastatic breast cancer and lung cancer using this combination optionally in combination with other anti-neoplastic agents or immune modulators are also described.


8. EP1858488B1 2013/9/11
专利标题:Tigecycline compositions and methods of preparation 法律状态
专利权人WYETH LLC;


9. EA018369B1 2013/7/30
专利标题:2-methyl-1-(phenylsulfonyl)-4-piperazin-1-yl-1h-benzimidazole, use thereof and composition comprising it 法律状态
专利权人WYETH LLC;
The invention relates to 2-methyl-1-(phenylsulfonyl)-4-(piperazin)-1-yl-1H-benzimidazole compounds or a pharmaceutically acceptable salt pharmaceutical composition and use thereof as a medicament and for modulation of 5-HTactivity.


10. EP2310011B1 2013/7/24
专利标题:Antineoplastic combinations containing hki-272 and vinorelbine 法律状态
专利权人WYETH LLC;



首页123456下页尾页172 条记录, 当前第1/18页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文